CurrentEndo
Get Weekly

Topic · page 76 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,001–3,040 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. J Clin Endocrinol Metab

    The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study

    Cross-sectional study

  2. Ann Intern Med

    Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease

    Research article

  3. Endocr Pract

    Prolonged Diabetic Ketoacidosis Associated With Sodium–Glucose Cotransporter-2 Inhibitors: A Review of Postmarketing Cases

    Cohort study

  4. Cardiovasc Diabetol

    Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI

    Cohort study

  5. Cardiovasc Diabetol

    The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes

    Cohort study

  6. Cardiovasc Diabetol

    Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus

    Mechanistic study

  7. Diabetes Care

    Glycemic Control, Cognitive Aging, and Impairment Among Diverse Hispanic/Latino Individuals: Study of Latinos– Investigation of Neurocognitive Aging (Hispanic Community Health Study/Study of Latinos)

    Cohort study

  8. Diabetes Obes Metab

    Once‐weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme

    Trial design

  9. Diabetes Obes Metab

    Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria

    Cohort study

  10. Cardiovasc Diabetol

    Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial

    Secondary analysis

  11. Cardiovasc Diabetol

    Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects

    Cross-sectional study

  12. Diabet Med

    Type 2 diabetes mellitus in patients with ischemic stroke – A nationwide study

    Cohort study

  13. BMJ

    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study

    Cohort study

  14. J Clin Endocrinol Metab

    Colorectal Cancer and Subsequent Diabetes Risk: A Population-Based Cohort Study in Taiwan

    Cohort study

  15. Diabetes Res Clin Pract

    Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus

    Case-control study

  16. Diabetes Res Clin Pract

    Are the cardiovascular properties of GLP-1 receptor agonists differentially modulated by sulfonylureas? Insights from post-hoc analysis of EXSCEL

    Secondary analysis

  17. Obesity (Silver Spring)

    Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study

    Cohort study

  18. Diabetes Care

    Early-Onset Hypertension and Sex-Specific Residual Risk for Cardiovascular Disease in Type 2 Diabetes

    Secondary analysis

  19. Diabetes Care

    Association of Water Arsenic With Incident Diabetes in U.S. Adults: The Multi-Ethnic Study of Atherosclerosis and the Strong Heart Study

    Cohort study

  20. Diabetologia

    Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study

    Cross-sectional study

  21. Diabetes Technol Ther

    Progression from Prediabetes to Diabetes in a Diverse U.S. Population: A Machine Learning Model

    Cohort study

  22. Diabetes Care

    Time-to-Event Genome-Wide Association Study for Incident Cardiovascular Disease in People With Type 2 Diabetes

    Research article

  23. Diabetes Res Clin Pract

    Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes

    Research article

  24. Diabetes Obes Metab

    Cross‐sectional, case‐control and longitudinal associations between exposure to glucagon‐like peptide‐1 receptor agonists and the dispensing of antidepressants

    Case-control study

  25. J Clin Endocrinol Metab

    Dipeptidyl Peptidase 4 Inhibitors vs Metformin for New-onset Dementia: A Propensity Score-matched Cohort Study

    Cohort study

  26. Cardiovasc Diabetol

    Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials

    Meta-analysis

  27. Diabetes Obes Metab

    Biotransformation and disposition characteristics of HSK7653 , a novel long‐acting dipeptidyl peptidase‐4 inhibitor for the treatment of type 2 diabetes

    Research article

  28. Diabetes Obes Metab

    C‐peptide index at 2 h post‐meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes

    Cohort study

  29. Diabetologia

    Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus

    Cohort study

  30. Diabetes Obes Metab

    Cardiorenal outcomes and mortality after sodium‐glucose cotransporter‐2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history

    Cohort study

  31. Diabetes Metab

    No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes

    Mechanistic study

  32. J Diabetes Sci Technol

    Glucose Color Index: Development and Validation of a Novel Measure of the Shape of Glycemic Variability

    Diagnostic or prognostic study

  33. Diabetes Care

    Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program

    Secondary analysis

  34. Ann Intern Med

    Cost-Effectiveness of Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review of Cost-Effectiveness Studies for the American College of Physicians

    Meta-analysis

  35. Ann Intern Med

    Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians

    Guideline or statement

  36. Ann Intern Med

    Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians

    Meta-analysis

  37. J Clin Endocrinol Metab

    Expression of Bile Acid Receptors and Transporters Along the Intestine of Patients With Type 2 Diabetes and Controls

    Mechanistic study

  38. Diabetes Care

    Effect of 5:2 Regimens: Energy-Restricted Diet or Low-Volume High-Intensity Interval Training Combined With Resistance Exercise on Glycemic Control and Cardiometabolic Health in Adults With Overweight/Obesity and Type 2 Diabetes: A Three-Arm Randomized Controlled Trial

    Randomized controlled trial

  39. J Clin Endocrinol Metab

    Genetic Underpinnings of Fasting and Oral Glucose-stimulated Based Insulin Sensitivity Indices

    Cohort study

  40. Diabetes Obes Metab

    Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies

    Meta-analysis

All 4,758 Briefs in ExploreShowing Briefs 3,001–3,040 of 4,758, newest first